LACTOLOGY FOUNDATION

Diphenhydramine (ATC A04AB05) is a first‑generation H1‑antihistamine with pronounced anticholinergic and sedative properties, used as an antiemetic antihistamine and associated with relevant toxicological and lactation‑related safety concerns.medpedia.framar+2

ATC class and pharmacological profile

Diphenhydramine under the ATC code A04AB05 belongs to the subgroup of antiemetic antihistamines used to prevent and treat nausea and vomiting, particularly motion‑related symptoms.rxlist+1
Pharmacologically it is a first‑generation histamine H1 receptor antagonist with significant anticholinergic, sedative, antiemetic and, to a lesser extent, local anesthetic activity.drugbank+2

Antihistamine action is mediated by competitive antagonism at peripheral and central H1 receptors, reducing histamine‑induced vasodilation, increased vascular permeability and sensory nerve stimulation.pediatriconcall+2
The anticholinergic effects (central and peripheral) contribute to antiemetic efficacy in vestibular disorders but also underlie many of the adverse reactions and toxic manifestations.rxlist+1

Clinical use within A04AB05

Within the antiemetic class, diphenhydramine is used for symptomatic treatment of nausea and vomiting, especially in motion sickness, vertigo and other vestibular syndromes, often as part of short‑term therapy.geekymedics+2
Beyond A04AB05, it is also widely used for allergic rhinitis, urticaria, pruritus, cold symptoms and short‑term treatment of insomnia, which is relevant when assessing cumulative exposure and safety in lactating patients.wikipedia+3

Typical adult oral doses for antiemetic or antihistamine indications are 25–50 mg every 4–6 hours, with maximum daily doses around 300 mg, while children receive weight‑ and age‑adjusted lower doses.medlineplus+1
In clinical practice, A04AB05 formulations are usually prescription‑only in many jurisdictions, reflecting the need for medical supervision due to central nervous system and anticholinergic risks.medpedia.framar+1

Toxicological considerations

Diphenhydramine has a narrow margin between therapeutic and toxic doses, and toxicity is largely driven by central H1 blockade combined with potent anticholinergic and sodium‑channel‑blocking effects.drugbank+1
Common dose‑related adverse effects include marked sedation, dizziness, cognitive slowing, dry mouth, blurred vision, tachycardia and urinary retention, all of which may compromise psychomotor performance.nhs+3

At higher doses or in susceptible individuals, serious reactions may include agitation, confusion, delirium, hallucinations, severe anticholinergic syndrome, arrhythmias and, in extreme overdose, seizures and coma.pediatriconcall+2
The anticholinergic profile makes diphenhydramine particularly risky in patients with narrow‑angle glaucoma, prostatic hypertrophy, urinary outflow obstruction, cardiovascular disease and in the elderly.nhs+2

From a pediatric standpoint, diphenhydramine is contraindicated in newborns and premature infants and should not be used to induce sleep; paradoxical excitation and serious toxicity have been described in overdose.medlineplus+1
Because elimination is mainly hepatic, dose reduction or cautious use is advised in significant hepatic impairment, and drug interactions with other CNS depressants or anticholinergics can potentiate toxicity.rxlist+1

Safety in lactation (toxico‑lactological focus)

Diphenhydramine passes into breast milk in small amounts, and occasional low‑dose, short‑term use in healthy, full‑term infants is generally considered compatible with breastfeeding when there is clear clinical need.pakpeds
However, its sedative and anticholinergic effects raise concerns about drowsiness, irritability or poor feeding in the breastfed infant, particularly at higher dosages or with repeated administration.grow.summerhealth+1

Regular or long‑term use may reduce milk production, as anticholinergic and antihistamine effects can interfere with prolactin‑mediated lactation, especially in the early postpartum period or in mothers with borderline milk supply.grow.summerhealth+1
For these reasons, diphenhydramine during breastfeeding should be limited to short courses, taken at the lowest effective dose, preferably in the evening after a feed, and avoided in mothers of preterm or high‑risk infants unless specialist advice supports use.pakpeds+1

Safer alternatives for allergy or mild nausea in breastfeeding women generally include non‑sedating second‑generation antihistamines, which have lower CNS penetration and fewer lactation‑related concerns.grow.summerhealth+1
Before prescribing or recommending A04AB05 medicines to lactating patients, consultation of specialized lactation resources (e.g. LactMed) and individual risk–benefit assessment are strongly advisable.pakpeds+1

Practical prescribing and monitoring notes

In lactating women, diphenhydramine should not be used chronically as a sleep aid, and repeated night‑time dosing may both worsen maternal alertness and subtly impact milk supply over time.wikipedia+1
Clinicians should counsel mothers to monitor infants for unusual somnolence, poor suck, feeding difficulties, or paradoxical irritability and to seek medical review if such symptoms appear temporally related to maternal dosing.grow.summerhealth+1

Given the neurocognitive and psychomotor impairment, mothers should be warned about driving, operating machinery or co‑sleeping with the infant when taking sedating doses, to minimize accident and suffocation risk.wikipedia+2
Dose adjustments or avoidance are recommended when other CNS depressants (opioids, benzodiazepines, alcohol) or anticholinergic drugs are used concomitantly, because combined toxicity may be clinically significant.pediatriconcall+1

In summary, A04AB05 diphenhydramine is a clinically useful antiemetic antihistamine, but in the context of lactation its use should be cautious, time‑limited and individualized, with preference for safer alternatives whenever feasible.medpedia.framar+2